alpha-L-iduronidase — Drug Target

All drugs that target alpha-L-iduronidase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Enzyme replacement therapy

Phase 2 pipeline (1)

• ALXN2030 · Alexion Pharmaceuticals, Inc. · Enzyme replacement therapy · Genetics and Rare Diseases
  ALXN2030 is a recombinant human alpha-L-iduronidase enzyme replacement therapy.